Description

(S)-Methyl 5-Oxo-5,6,7,8-Tetrahydroimidazo[1,5-C]Pyrimidine-7-Carboxylate is a high-purity chiral intermediate of significant importance in advanced pharmaceutical synthesis. This compound serves as a critical building block for the development of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring stereochemical precision. It is primarily needed by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers engaged in the synthesis of complex heterocyclic molecules.

Application

• Pharmaceutical Intermediate: A key chiral synthon in the research and development of new drug candidates, especially for central nervous system (CNS) and oncology targets.
• API Synthesis: Used in the multi-step synthesis of complex Active Pharmaceutical Ingredients (APIs) where the (S)-configuration is crucial for biological activity.
• Asymmetric Catalysis Research: Serves as a substrate or ligand precursor in studies exploring new asymmetric synthetic methodologies.
• Chemical Biology Probes: Utilized in the design and synthesis of molecular probes for studying enzyme mechanisms and biological pathways.
• Process Chemistry Development: Employed in scaling up synthetic routes from laboratory to pilot plant and commercial production.
• Custom Synthesis & Contract Manufacturing: A vital starting material for CDMOs (Contract Development and Manufacturing Organizations) producing bespoke compounds for clients.

Basic Information

Product Name	(S)-Methyl 5-Oxo-5,6,7,8-Tetrahydroimidazo[1,5-C]Pyrimidine-7-Carboxylate
CAS No.	69614-04-6
Molecular Formula	C9H9N3O3
Molecular Weight	207.19 g/mol
Synonyms	(S)-Methyl 5-oxo-6,7,8,9-tetrahydroimidazo[1,5-c]pyrimidine-7-carboxylate; Methyl (6S)-5-oxo-6,7,8,9-tetrahydroimidazo[1,5-c]pyrimidine-7-carboxylate; (S)-5-Oxo-5,6,7,8-tetrahydroimidazo[1,5-c]pyrimidine-7-carboxylic acid methyl ester; (S)-7-(Methoxycarbonyl)-5,6,7,8-tetrahydroimidazo[1,5-c]pyrimidin-5-one; 69614-04-6; (S)-enantiomer of Methyl 5-oxo-5,6,7,8-tetrahydroimidazo[1,5-c]pyrimidine-7-carboxylate
EINECS	Contact for details

Quality Control

Our (S)-Methyl 5-Oxo-5,6,7,8-Tetrahydroimidazo[1,5-C]Pyrimidine-7-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral purity verification by HPLC, to ensure it meets the high standards required for pharmaceutical R&D and synthesis. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified for long-term storage.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Assay (HPLC)	≥98.0%
Chiral Purity (HPLC)	≥99.0% ee
Loss on Drying	≤0.5%
Residue on Ignition	≤0.1%
Heavy Metals	≤10 ppm
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.